🎉 Up to 70% Off Selected ItemsShop Sale
Product image 1
Product image 2
Product image 3
Product image 4
HomeStore

Amlovan Hct 10Mg/160Mg/25Mg 28 Tablets

Amlovan Hct 10Mg/160Mg/25Mg 28 Tablets

A prescription combination tablet formulated to lower high blood pressure by relaxing blood vessels and reducing fluid volume, whose hypertension is not adequately managed with mono‑ or dual therapy.

Indications:
‑ Treatment of essential hypertension (high blood pressure) in adults.
- Helping to improve cardiovascular risk control in adults whose hypertension is not adequately managed with mono‑ or dual therapy.

Main Active Ingredients:
‑ Amlodipine Besylate 10 mg.
‑ Valsartan 160 mg.
‑ Hydrochlorothiazide 25 mg.

Precautions:
‑ Not for use in patients with known hypersensitivity to amlodipine, valsartan, hydrochlorothiazide, or sulphonamides.
‑ Use with caution in severe liver or kidney impairment; periodic monitoring of electrolytes recommended.
‑ Avoid use in the second and third trimesters of pregnancy.
‑ Inform healthcare provider if taking potassium supplements or other antihypertensives.

Side Effects:
‑ Dizziness or light‑headedness (especially on standing).
‑ Headache.
‑ Peripheral edema (ankle or foot swelling).
‑ Electrolyte imbalances (e.g., low potassium) due to hydrochlorothiazide.
‑ Fatigue or weakness.

Drug‑Drug Interactions:
‑ May have additive blood pressure‑lowering effects with other antihypertensives.
‑ NSAIDs (e.g., ibuprofen) can reduce antihypertensive efficacy.
‑ Caution when combined with lithium or potassium‑sparing diuretics due to electrolyte disturbances.
$1.55

Original: $4.44

-65%
Amlovan Hct 10Mg/160Mg/25Mg 28 Tablets—

$4.44

$1.55

Product Information

Shipping & Returns

Description

A prescription combination tablet formulated to lower high blood pressure by relaxing blood vessels and reducing fluid volume, whose hypertension is not adequately managed with mono‑ or dual therapy.

Indications:
‑ Treatment of essential hypertension (high blood pressure) in adults.
- Helping to improve cardiovascular risk control in adults whose hypertension is not adequately managed with mono‑ or dual therapy.

Main Active Ingredients:
‑ Amlodipine Besylate 10 mg.
‑ Valsartan 160 mg.
‑ Hydrochlorothiazide 25 mg.

Precautions:
‑ Not for use in patients with known hypersensitivity to amlodipine, valsartan, hydrochlorothiazide, or sulphonamides.
‑ Use with caution in severe liver or kidney impairment; periodic monitoring of electrolytes recommended.
‑ Avoid use in the second and third trimesters of pregnancy.
‑ Inform healthcare provider if taking potassium supplements or other antihypertensives.

Side Effects:
‑ Dizziness or light‑headedness (especially on standing).
‑ Headache.
‑ Peripheral edema (ankle or foot swelling).
‑ Electrolyte imbalances (e.g., low potassium) due to hydrochlorothiazide.
‑ Fatigue or weakness.

Drug‑Drug Interactions:
‑ May have additive blood pressure‑lowering effects with other antihypertensives.
‑ NSAIDs (e.g., ibuprofen) can reduce antihypertensive efficacy.
‑ Caution when combined with lithium or potassium‑sparing diuretics due to electrolyte disturbances.